Published on: November 09, 2020 at 10:30PM
Conditions: Diabetes Mellitus, Type 2; Impaired Renal Function
Intervention: Drug: Dapagliflozin 10 MG [Farxiga]
Sponsors: George Clinical Pty Ltd; University Medical Center Groningen; Ground Zero Pharmaceuticals
Not yet recruiting
https://ift.tt/3n7Mg5a
Monday, 9 November 2020
New diabetes clinical trial: DAPASALT: An Open Label, Phase IV, Mechanistic, Study to Evaluate the Natriuretic Effect of 2-Week Dapagliflozin Treatment in Type 2 Diabetes Mellitus Patients With Impaired Renal Function
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Nothing happens without a Reason
Make Something out of it.